Prostate-specific antigen test for prostate cancer screening: American Society of Clinical Oncology provisional clinical opinion.
作者信息
Nam Robert K, Oliver Thomas K, Vickers Andrew J, Thompson Ian, Kantoff Philip W, Parnes Howard L, Loblaw Andrew, Roth Bruce J, Williams Jim, Temin Sarah, Basch Ethan
机构信息
Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
出版信息
J Oncol Pract. 2012 Sep;8(5):315-7. doi: 10.1200/JOP.2012.000715.
Abstract
摘要
相似文献
1
Prostate-specific antigen test for prostate cancer screening: American Society of Clinical Oncology provisional clinical opinion.
J Oncol Pract. 2012 Sep;8(5):315-7. doi: 10.1200/JOP.2012.000715.
2
Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion.
J Clin Oncol. 2012 Aug 20;30(24):3020-5. doi: 10.1200/JCO.2012.43.3441. Epub 2012 Jul 16.
3
Prostate cancer screening.
Curr Oncol Rep. 2011 Feb;13(1):57-62. doi: 10.1007/s11912-010-0136-x.
4
Educational Material on Prostate Cancer Screening is Overly Complex and Fails to Meet Recommended Layperson Readability Guidelines.
Urology. 2020 Jan;135:1-3. doi: 10.1016/j.urology.2019.10.006. Epub 2019 Oct 24.
5
Declining Incidence Rates of Prostate Cancer in the United States: Is This Good News or Not?
JAMA Oncol. 2017 Dec 1;3(12):1623-1624. doi: 10.1001/jamaoncol.2017.0470.
6
Navigating Prostate Cancer Screening in the Real World of Primary Care: The Mirage and the Quicksand.
JAMA Oncol. 2018 Apr 1;4(4):453-454. doi: 10.1001/jamaoncol.2017.5682.
7
Screening for Prostate Cancer.
Am Fam Physician. 2018 Oct 15;98(8):537-538.
8
Screening for Prostate Cancer: Recommendation Statement.
Am Fam Physician. 2018 Oct 15;98(8):Online.
9
Recent Patterns of Prostate-Specific Antigen Testing for Prostate Cancer Screening in the United States.
JAMA Intern Med. 2017 Jul 1;177(7):1040-1042. doi: 10.1001/jamainternmed.2017.0340.
10
Counseling Patients About Prostate Cancer Screening.
Am Fam Physician. 2018 Oct 15;98(8):478-483.
引用本文的文献
1
Expected impact of MRI-targeted biopsy interreader variability among uropathologists on ProScreen prostate cancer screening trial: a pre-trial validation study.
World J Urol. 2024 Apr 6;42(1):217. doi: 10.1007/s00345-024-04898-2.
2
Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial.
Pharmacoeconomics. 2022 Dec;40(12):1207-1220. doi: 10.1007/s40273-022-01191-1. Epub 2022 Oct 6.
3
Prostate cancer screening-when to start and how to screen?
Transl Androl Urol. 2018 Feb;7(1):34-45. doi: 10.21037/tau.2017.12.25.
4
Prostate cancer prediction using the random forest algorithm that takes into account transrectal ultrasound findings, age, and serum levels of prostate-specific antigen.
Asian J Androl. 2017 Sep-Oct;19(5):586-590. doi: 10.4103/1008-682X.186884.
5
Our shifting understanding of factors influencing prostate-specific antigen.
J Natl Cancer Inst. 2013 Sep 4;105(17):1264-5. doi: 10.1093/jnci/djt218. Epub 2013 Aug 13.
6
Evaluation of phage display discovered peptides as ligands for prostate-specific membrane antigen (PSMA).
PLoS One. 2013 Jul 25;8(7):e68339. doi: 10.1371/journal.pone.0068339. Print 2013.
本文引用的文献
1
Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion.
J Clin Oncol. 2012 Aug 20;30(24):3020-5. doi: 10.1200/JCO.2012.43.3441. Epub 2012 Jul 16.
2
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med. 2012 Jul 17;157(2):120-34. doi: 10.7326/0003-4819-157-2-201207170-00459.
3
Prostate-cancer mortality at 11 years of follow-up.
N Engl J Med. 2012 Mar 15;366(11):981-90. doi: 10.1056/NEJMoa1113135.
4
Cancer statistics, 2012.
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
5
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.
J Natl Cancer Inst. 2012 Jan 18;104(2):125-32. doi: 10.1093/jnci/djr500. Epub 2012 Jan 6.
6
Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.
Ann Intern Med. 2011 Dec 6;155(11):762-71. doi: 10.7326/0003-4819-155-11-201112060-00375. Epub 2011 Oct 7.
7
Complications after prostate biopsy: data from SEER-Medicare.
J Urol. 2011 Nov;186(5):1830-4. doi: 10.1016/j.juro.2011.06.057. Epub 2011 Sep 23.
8
Prostate cancer screening 2010: updated recommendations from the American Cancer Society.
J Natl Med Assoc. 2010 May;102(5):423-9. doi: 10.1016/s0027-9684(15)30578-2.
9
Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.
J Urol. 2010 Mar;183(3):963-8. doi: 10.1016/j.juro.2009.11.043. Epub 2010 Jan 20.
10
Prostate specific antigen best practice statement: 2009 update.
J Urol. 2009 Nov;182(5):2232-41. doi: 10.1016/j.juro.2009.07.093. Epub 2009 Sep 24.
Zotero 插件